Certifications
American Board of Internal Medicine (Hematology)
American Board of Internal Medicine (Medical Oncology) (Certification Date: 11-01-2017 )
Clinical Interests
Hematology
Hematology and Oncology
Leukemia
Malignant Melanoma
Oncology
Acute Lymphocytic Leukemia
Bone Marrow Cancers
Cancer
Myeloma
Specialities
Internal Medicine
Publications
Peer Reviewed Publications
Zayad, Anas; Ahmed, Nausheen; Mahmoudjafari, Zahra; Skikne, Barry S; Lin, Tara; Mushtaq, Muhammad U; McGuirk, Joseph; Lutfi, Forat; Bhurtel, Evguenia; Bhutani, Manisha; Anwar, Faiz; Alkharabsheh, Omar; Shebli, Atrash; Abdallah, Al-Ola (2025. ) The Impact of Sponsors on Development of Clinical Research in Multiple Myeloma and AL Amyloidosis: An In-Depth Analysis.Clinical lymphoma, myeloma & leukemia, , 25 (8 ) ,e600-e603 More Information
Mewawalla, Prerna; Dileo, Rachel; Yin, Yue; Strouse, Christopher; Shaikh, Hira; Davis, James A; Alkharabsheh, Omar; Rashid, Aliya; Ahmed, Nausheen; Abdallah, Al-Ola; Hashmi, Hamza (2025. ) Real-World Outcomes of Sequential BCMA-directed therapies in Relapsed Refractory Multiple Myeloma After Belantamab Exposure.Clinical lymphoma, myeloma & leukemia, , More Information
Dileo, Rachel; Mewawalla, Prerna; Babu, Kalaivani; Yin, Yue; Strouse, Christopher; Chen, Ethan; Shaikh, Hira; Davis, James A; Green, Kimberly M; Alkharabsheh, Omar; Rashid, Aliya; Pokhrel, Bidushi; Ahmed, Nausheen; Abdallah, Al-Ola; Hashmi, Hamza (2025. ) A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma.Blood cancer journal, , 15 (1 ) ,34 More Information
Atallah, Rawan; Ahmed, Nausheen; Ayoobkhan, Fathima; Saif, Md Saiful Islam; Logan, Emerson; Shrestha, Anuj; Anwer, Faiz; Mahmoudjafari, Zahra; Mushtaq, Muhammed Umair; Hashmi, Hamza; Ganguly, Siddhartha; McGuirk, Joseph; Shebli, Atrash; Abdallah, Al-Ola; Banerjee, Rahul; Alkharabsheh, Omar (2024. ) TACTUM: Trends in Access to Cellular Therapies in Multiple Myeloma, Perspectives of Treating Versus Referring Physicians.Transplantation and cellular therapy, , 30 (9 ) ,925.e1-925.e6 More Information
Afrough, Aimaz; Atrash, Shebli; Paul, Barry; Ouchveridze, Evguenia; Ahmed, Nausheen; Mahmoudjafari, Zahra; Bashir, Anam; Alkharabsheh, Omar; Hashmi, Hamza; Abdallah, Al-Ola (2023. ) Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab-Naïve Relapsed Multiple Myeloma.Cancers, , 15 (19 ) , More Information
Manne, Ashish; Mulekar, Madhuri; Escobar, Daisy; Prodduturvar, Pranitha; Fahmawi, Yazan; Henderson, Phillip; Abdul-Rahim, Osama; Hussain, Zeiad; Liles, Spencer; Fonseca, Annabelle; Howard, John Harrison; Mneimneh, Wadad; Gilbert, Robert; Alkharabsheh, Omar; Pai, Sachin; White, Zachary B; Nelson, Cindy; Khushman, Moh'd (2023. ) The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.Journal of cancer research and therapeutics, , 19 (5 ) ,1103-1108 More Information
Abdallah, Al-Ola; Mahmoudjafari, Zahra; Ahmed, Nausheen; Cui, Wei; Shune, Leyla; McGuirk, Joseph; Mohan, Meera; Mohyuddin, Ghulam Rehman; Afrough, Aimaz; Alkharabsheh, Omar; Atrash, Shebli (2023. ) Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.European journal of haematology, , 110 (6 ) ,626-632 More Information
Atrash, Shebli; Mammadzadeh, Aytaj; Peng, Fulei; Alkharabsheh, Omar; Afrough, Aimaz; Cui, Wei; Mahmoudjafari, Zahra; Abdallah, Al-Ola; Hashmi, Hamza (2023. ) Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy.Cancers, , 15 (11 ) , More Information
Alkharabsheh, Omar; Bellman, Polina; Mahmoudjafari, Zahra; Cui, Wei; Atrash, Shebli; Paul, Barry; Hashmi, Hamza; Shune, Leyla; Ahmed, Nausheen; Abdallah, Al-Ola (2023. ) Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexamethasone.Journal of hematology, , 12 (1 ) ,1-6 More Information
Njomen, Evert; Vanecek, Allison; Lansdell, Theresa A; Yang, Ya-Ting; Schall, Peter Z; Harris, Christi M; Bernard, Matthew P; Isaac, Daniel; Alkharabsheh, Omar; Al-Janadi, Anas; Giletto, Matthew B; Ellsworth, Edmund; Taylor, Catherine; Tang, Terence; Lau, Sarah; Bailie, Marc; Bernard, Jamie J; Yuzbasiyan-Gurkan, Vilma; Tepe, Jetze J (2022. ) Small Molecule 20S Proteasome Enhancer Regulates MYC Protein Stability and Exhibits Antitumor Activity in Multiple Myeloma.Biomedicines, , 10 (5 ) , More Information
Alkharabsheh, Omar; Trisel, Zachary; Badami, Sunil; Aljama, Mohammed A; Sidiqi, M Hasib (2021. ) Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises.Cancers, , 14 (1 ) , More Information
Khushman, Moh'd; Prodduturvar, Pranitha; Mneimneh, Wadad; Zotto, Valeria Dal; Akbar, Shalla; Grimm, Leander; Rider, Paul; Hunter, John; Alkharabsheh, Omar; Patel, Girijesh Kumar; Fabregas, Jesus C; Singh, Ajay P (2021. ) The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma.Oncotarget, , 12 (15 ) ,1490-1498 More Information
Manne, Ashish; Mulekar, Madhuri S; Escobar, Daisy E; Alsayed, Alhareth; Sharma, Gaurav; Prodduturvar, Pranitha; Khushman, Moh'd; Howard, John Harrison; Gilbert, Robert; Alkharabsheh, Omar (2021. ) Clinical and Hematological Predictors of High-Grade Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors.Journal of clinical medicine research, , 13 (5 ) ,268-275 More Information
Alkharabsheh, Omar; Alsayed, Alhareth; Morlote, Diana M; Mehta, Amitkumar (2021. ) Cerebral Invasive Aspergillosis in a Case of Chronic Lymphocytic Leukemia with Bruton Tyrosine Kinase Inhibitor.Current oncology (Toronto, Ont.), , 28 (1 ) ,837-841 More Information
Fahmawi, Yazan; Smith, Clayton; Grimm, Leander; Khullar, Shikha; Rider, Paul; Hunter, John; Iliff, Greire; Mneimneh, Wadad; Roveda, Kelly; Wang, Bin; Prodduturvar, Pranitha; Alkharabsheh, Omar; McCormick, Ben; Mizrahi, Meir; Khushman, Moh'd (2020. ) Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.Clinical colorectal cancer, , 19 (4 ) ,e281-e287 More Information
Alkharabsheh, Omar; Patnaik, Mrinal M; Gangat, Naseema; Begna, Kebede H; Alkhateeb, Hassan B; Shah, Mithun Vinod; Hogan, William J; He, Rong; Greipp, Patricia; Nguyen, Phuong L; Litzow, Mark R; Al-Kali, Aref (2020. ) Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system.Annals of hematology, , 99 (3 ) ,513-518 More Information
Alkharabsheh, Omar; Sidiqi, M Hasib; Aljama, Mohammed A; Gertz, Morie A; Frankel, Arthur E (2020. ) The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors.Acta haematologica, , 143 (2 ) ,118-123 More Information
Fahmawi, Yazan; Campos, Yesica; Khushman, Moh'd; Alkharabsheh, Omar; Manne, Ashish; Zubair, Haseeb; Haleema, Saadia; Polski, Jacek; Bessette, Sabrina (2019. ) Vitamin B12 deficiency presenting as pseudo-thrombotic microangiopathy: a case report and literature review.Clinical pharmacology : advances and applications, , 11 ,127-131 More Information
Alkharabsheh, Omar A; Saadeh, Salwa S; Zblewski, Darci L; Gangat, Naseema; Begna, Kebede H; Elliott, Michelle A; Alkhateeb, Hassan B; Patnaik, Mrinal S; Hogan, William J; Litzow, Mark R; Al-Kali, Aref (2019. ) Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy.Annals of hematology, , 98 (2 ) ,331-337 More Information
Alkharabsheh, Omar; Frankel, Arthur E (2019. ) Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies.Biomedicines, , 7 (1 ) , More Information
Alkharabsheh, Omar; Saadeh, Salwa S; Patnaik, Mrinal S; Alkhateeb, Hassan; Gangat, Naseema; Begna, Kebede H; Hogan, William J; Greipp, Patricia T; He, Rong; Nguyen, Phuong L; Litzow, Mark R; Al-Kali, Aref (2018. ) Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes.American journal of hematology, , 93 (12 ) ,E398-E401 More Information
Alkharabsheh, Omar; Al-Kali, Aref; Saadeh, Salwa; He, Rong; Viswanatha, David; Greipp, Patricia; Reichard, Kaaren; Shah, Mithun; Gangat, Naseema; Patnaik, Mrinal; Hogan, William; Litzow, Mark; Alkhateeb, Hassan; Nguyen, Phuong L (2018. ) The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS.American journal of hematology, , 93 (11 ) ,E355-E357 More Information
Alkharabsheh, Omar; Kannarkatt, Paul; Kannarkatt, Joseph; Karapetyan, Lilit; Laird-Fick, Heather S; Al-Janadi, Anas (2018. ) An overview of the toxicities of checkpoint inhibitors in older patients with cancer.Journal of geriatric oncology, , 9 (5 ) ,451-458 More Information
Kannarkatt, Joseph; Alkharabsheh, Omar; Tokala, Hemasri; Dimitrov, Nikolay V (2016. ) Metformin and Angiogenesis in Cancer - Revisited.Oncology, , 91 (4 ) ,179-184 More Information